Medimmune Limited

Phillip David Monk

Ralph Raymond Minter

Celia Patricia Shorrock

Lutz Jermutus

Karin Von Wachenfeldt

Claire Louise Dobson

Suzanne E Cohen

Duncan James Cochrane

Per-Olof Fredrik Eriksson

Lutz Ulrich Jochen Jermutus

James Jonathan Welch Roberts

Victoria Jane Tear

Specific binding members, in particular human anti-IL-13 antibody molecules and especially those which neutralize IL-13 activity. Methods for using anti-IL-13 antibody molecules in diagnosis or treatment of IL-13 related disorders, including asthma, atopic dermatitis, allergic rhinitis, fibrosis, inflammatory bowel disease and Hodgkin's lymphoma.

Human antibody molecules for IL-13

Specific binding members, in particular human anti-IL-13 antibody molecules and especially those which neutralise IL-13 activity. Methods for using anti-IL-13 antibody molecules in diagnosis or treatment of IL-13 related disorders, including asthma, atopic dermatitis, allergic rhinitis, fibrosis, inflammatory bowel disease and Hodgkin's lymphoma.

Methods of treatment using human antibody molecules for IL-13

This invention relates to binding members, especially antibody molecules, for IgE. The binding members are useful for, inter alia, treatment of disorders mediated by IgE including allergies and asthma.

Binding members for IgE molecules

Growing community of inventors

Cambridge, United Kingdom

Phillip David Monk